Monopar Therapeutics (MNPR) Other Gross PP&E Adjustments (2020 - 2025)
Quarterly results put Other Gross PP&E Adjustments at -$277010.0 for Q4 2025, changed N/A from a year ago — trailing twelve months through Dec 2025 was -$277010.0 (changed N/A YoY), and the annual figure for FY2025 was -$277010.0, changed.
Monopar Therapeutics has reported Other Gross PP&E Adjustments over the past 5 years, most recently at -$277010.0 for Q4 2025.
- Other Gross PP&E Adjustments reached -$277010.0 in Q4 2025 per MNPR's latest filing, down from -$115230.0 in the prior quarter.
- Across five years, Other Gross PP&E Adjustments topped out at -$9102.0 in Q1 2025 and bottomed at -$813644.0 in Q4 2023.
- Median Other Gross PP&E Adjustments over the past 4 years was -$84363.0 (2022), compared with a mean of -$235215.0.
- Peak annual rise in Other Gross PP&E Adjustments hit 65.58% in 2023, while the deepest fall reached 17.69% in 2023.
- Over 4 years, Other Gross PP&E Adjustments stood at -$700208.0 in 2021, then rose by 1.27% to -$691341.0 in 2022, then dropped by 17.69% to -$813644.0 in 2023, then skyrocketed by 65.95% to -$277010.0 in 2025.
- Business Quant data shows Other Gross PP&E Adjustments for MNPR at -$277010.0 in Q4 2025, -$115230.0 in Q3 2025, and -$128520.0 in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Gross PP&E Adjustments (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | -83,048.00 |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | -60,691.22 |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | -285.20 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | -892,000.00 |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | -1.69 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | - |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | -189.30 Mn |
| 10 | Monopar Therapeutics | 466.82 Mn | 466.82 Mn | - | -277,010.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -277,010.00 |
| Dec 31, 2025 | -277,010.00 |
| Sep 30, 2025 | -115,230.00 |
| Sep 30, 2025 | -115,230.00 |
| Jun 30, 2025 | -128,520.00 |
| Jun 30, 2025 | -128,520.00 |
| Mar 31, 2025 | -9,102.00 |
| Mar 31, 2025 | -9,102.00 |
| Dec 31, 2023 | -813,644.00 |
| Dec 31, 2023 | -813,644.00 |
| Sep 30, 2023 | -25,088.00 |
| Sep 30, 2023 | -25,088.00 |
| Jun 30, 2023 | -37,330.00 |
| Jun 30, 2023 | -37,330.00 |
| Mar 31, 2023 | -49,376.00 |
| Mar 31, 2023 | -49,376.00 |
| Dec 31, 2022 | -691,341.00 |
| Dec 31, 2022 | -691,341.00 |
| Sep 30, 2022 | -72,889.00 |
| Sep 30, 2022 | -72,889.00 |
| Jun 30, 2022 | -84,363.00 |
| Jun 30, 2022 | -84,363.00 |
| Mar 31, 2022 | -53,694.00 |
| Mar 31, 2022 | -53,694.00 |
| Dec 31, 2021 | -700,208.00 |
| Dec 31, 2021 | -700,208.00 |
| Dec 31, 2020 | -611,903.00 |
| Dec 31, 2020 | -611,903.00 |